🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

19 notícias encontradas para "live"
Foto: Markus Winkler / Pexels
Dicas
US private equity firm Apollo enters bidding war for easyJet with £5.7bn offer
Airline’s board minded to recommend deal – after accepting rival one from Castlelake earlier this weekBusiness live – latest updatesThe board of easyJet has given the green light to a possible £5.7bn offer from the US private equity firm Apollo, as the low-cost airline becomes the subject of a surprise bidding war.The company’s board said on Friday that it was “minded to recommend” the potential all-cash offer, which values the business at £7.15 a share, to shareholders. Continue readi
Foto: Sam Jotham Sutharson / Pexels
Dicas
Oasis reunion helps draw record 25m ‘music tourists’ to UK concerts
Gigs by Gallagher brothers, Coldplay, Lana Del Rey and Beyonce gives £11bn boost to the economyBig name artists including Oasis with their highly anticipated reunion tour, Coldplay and Beyoncé helped to attract a record number of fans to travel to watch live music last year, helped by a surge in overseas visitors at UK gigs.A report from the industry body UK Music estimated that 24.7 million “music tourists” attended concerts and festivals last year, up 4.8% on 2024, leading to an unpr
Foto: Ramazan Toygun / Pexels
Dicas
This thinktank exposed fat cats and obscenely high pay. Guess what has happened to it? | Polly Toynbee
The High Pay Centre revealed the excesses of CEO wages. But then anti-diversity winds blew in from across the AtlanticShock ricocheted around the world of social research this week with the sudden news of the imminent closure of the High Pay Centre (HPC). Founded in 2011 by the former Guardian business editor Deborah Hargreaves to focus on analysis of extreme pay at the top and the widening pay gap between CEOs and their average employees, its closure feels like the death of an idea.Ot
Foto: Brett Sayles / Pexels
Dicas
The fight against AI data centers is important – but it’s just a starting point | Bruce Schneier and Nathan E Sanders
AI companies want to capture the value created by entire industries. That concentration of wealth and power is society’s greatest riskOpposition to AI datacenters has emerged as a primary theme in US politics, one that – surprisingly – doesn’t fall along party lines. We applaud people coming together for constructive debate on any issue, and agree that communities need to evaluate whether any economic benefits these datacenters bring is worth their costs. Still, we worry that a focus o
Foto: Jakub Zerdzicki / Pexels
Dicas
Five pressing questions for Reform UK about its finances
Questions swirl about origins of gifts, loans and donations as even party supporters wonder if it can weather the stormUK politics live – latest updatesWhy is Farage quitting as an MP, only to stand again?Scrutiny is mounting on Reform UK’s finances.On Tuesday, amid an investigation by parliamentary standards into an undisclosed £5m gift, Nigel Farage announced he would resign and trigger a byelection in his constituency of Clacton-on-Sea. Continue reading...
Foto: Nic Wood / Pexels
Dicas
Invest in Britain or I’ll force you to, minister tells pension funds
Business secretary Peter Kyle says asset managers should feel a patriotic duty to make the UK a successBusiness live – latest updatesThe business secretary, Peter Kyle, has warned UK pension funds to “get off their high horses” and invest in Britain or be forced to do so by law.Expressing frustration at the level of investment in British companies after years of government initiatives, Kyle said the UK’s biggest asset managers “should feel a patriotic duty in making Britain a success”.
Foto: Mitchell Henderson / Pexels
Dicas
UK housing market downturn eases but sentiment remains ‘fragile’, surveyors say – business live
Brent crude dips slightly below $78 a barrel; most Asian stock markets bounce backBritain’s second-biggest drugmaker GSK has also taken a hit from recent drug failures.The Californian biotech Alector has said that GSK has ended their neuroscience collaboration covering ​two experimental antibody drugs, after both drug candidates suffered setbacks in clinical trials.The CARDIO-TTRansform trial was designed to examine the role of Wainua, a gene silencer treatment, on top of today’s stand